Pharmaceutical Industry
A big pharma move - Politico
MAHA report blames 'overmedicalization,' pharma's influence for children's poor health - Fierce Healthcare
CDMO Samsung Biologics telegraphs spinoff of biosim unit - Fierce Pharma
Poland hits a wall trying to curb Big Pharma’s profits - politico.eu
Jiangsu Hengrui jumps 25% in solid Hong Kong trading debut - South China Morning Post
Big Pharma Puppet Groups Are Keeping Your Drug Prices High - Jacobin
The ‘MAHA report’: Four key takeaways on vaccines, medicine and the pharma industry - Endpoints News
The Top 5 Most Active Corporate VCs in Pharma - BioSpace
Drugs Licensed
Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake - Reuters
Connecticut medical board restricts the license of Stamford doctor for 'excessively using drugs' - Trumbull Times
Proposed legislation paves the way for AI to prescribe drugs - MobiHealthNews
Here are 8 FDA-approved medications for weight loss - NewsNation
CDER Bioresearch Monitoring: Electronic Submission Requirements for New Drug and Biologic Licensing Applications - fda.gov
Department of Drug and Alcohol Programs - Commonwealth of Pennsylvania (.gov)
Synthetic Approaches to the New Drugs Approved during 2023 - ACS Publications
Determining the optimal use of approved drugs in oncology - The Lancet
Oncology Drugs Approved by the FDA in March 2025 - Oncology Nursing News
Drugs Patents
Donald Trump urged to target ‘lazy patent expansion’ in US drug bill push - Financial Times
One in Five FDA-Approved Drugs Face Early Patent Challenges, Study Finds. - geneonline.com
FTC Renews Crackdown on ‘Improperly Listed’ Drug-Device Patents - Bloomberg Law News
EPO revokes another Novo Nordisk patent behind Ozempic and Wegovy drugs - JUVE Patent
Second Medical Use Patents In Brazil - Mondaq
Sponsored Content: The Connection Between Patents and High Drug Prices - Politico
Does Pharma Need Patents? - The Yale Law Journal
Reduce drug spending by drastically simplifying monopolies on drugs - statnews.com
How GLP-1 drug patents worsen healthcare disparities - TechTarget
Drugs Generics
What Is The Right Price To Pay For Drugs? (Part I) – OpEd - Eurasia Review
Generic drugs can be reliably supplied at big savings, study finds - Medical Xpress
Civica touts a study that ‘validates’ its model for selling low-cost generics - statnews.com
United States Generic Drugs Market Analysis Report - GlobeNewswire
Share of generics in Russian pharma market steadily growing - The Pharma Letter
Pharmacists Stockpile Most Common Drugs on Chance of Targeted Trump Tariffs - KFF Health News
All generic drugs are not equal, study finds - Ohio State News
What Patients Say Matters: How AI Analyzes Sentiment to Improve Generic Drug Oversight - Pharmaceutical Online
Attorney General Bonta Urges Consumers to Check Eligibility for Compensation for Inflated Generic Drug Prices - State of California - Department of Justice (.gov)
FDA Food and Drug Administration
FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation - CNN
FDA Issues Warning About Rare But Severe Reaction When Stopping Allergy Medications - People.com
Feeling itchy? FDA warns about rare side effect from some allergy drugs - USA Today
Popular allergy medications linked to severe withdrawal symptoms, FDA warns - Fox News
GSK's asthma drug wins FDA approval to treat 'smoker's lung' - Reuters
First FDA-cleared Alzheimer's blood test could make diagnoses faster, more accurate - NPR
FDA crackdown on off-brand weight loss and diabetes drugs to take effect - WESH
New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect - PR Newswire
FDA cracking down on Ozempic copycats, potentially slimming options for consumers - New York Post
Pharmaceutical Companies
A big pharma move - Politico
Meet the ‘first sale’ rule: A customs loophole pharma companies could use to ease tariff impact - Endpoints News
Big Pharma Puppet Groups Are Keeping Your Drug Prices High - Jacobin
Poland hits a wall trying to curb Big Pharma’s profits - politico.eu
Can pharma tariffs “Make America Manufacture Again”? - Pharmaceutical Technology
Effects of Executive Order Could Take Years to Appear: John Barkett, MBA - AJMC
Drug Trade Group Lobs Latest Challenge to Tennessee Pharmacy Law - Bloomberg Law News
Novartis bets on ageing as next frontier in drug development - SWI swissinfo.ch
MAHA report blames 'overmedicalization,' pharma's influence for children's poor health - Fierce Healthcare
Retail Pharmacies
CVS, some Walgreens stores, exiting Arkansas - The Arkansas Democrat-Gazette
New data show Ohio pharmacy closures in 2024 were even worse than originally reported - Canton Repository
Court approves fire sale of most of Rite Aid's pharmacy assets - Reuters
Four major retail and pharmacy chains close Sacramento stores - Sacramento Bee
Q&A: The New Technology Helping Pharmacies Facilitate Drug Shortages - Drug Topics
Walmart Opens Largest Prescription-Processing Facility - Progressive Grocer
GoodRx to Launch Direct Contracting for Independent Community Pharmacies - Business Wire
Retail pharmacies prioritize the democratization of health - Drug Store News
How pharmacies feel about Optum Rx’s new reimbursement strategy - Healthcare Brew
Drug Marketing
The impact of accelerated drug marketing registration procedures on the review and approval of new drugs in China - Nature
Drug Patent Watch Report: Generic Drug Manufacturers Advised to Prioritize Strategic Planning, Market Research, and Operational Efficiency for Success. - geneonline.com
Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China - Investopedia
China Issues New Domestic Responsible Person Rules for Foreign Drug Marketing Authorization Holders - Morgan Lewis
Judge levies $1.64B penalty on Johnson & Johnson in HIV drug marketing case - Fierce Pharma
Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case - Reuters
7th Circ. Weighs AbbVie Whistleblower's Drug Marketing Suit - Law360
Opinion | Why Hasn't RFK Jr. Paused Drug Ads? - MedPage Today
FDA Authorizes Marketing of 20 ZYN Nicotine Pouch Products after Extensive Scientific Review - fda.gov